186 related articles for article (PubMed ID: 16925131)
1. Advancing access to myeloma treatment: administration, side effects, and implications for survival.
Davies MJ
ONS News; 2006; 21(8 Suppl):11-2. PubMed ID: 16925131
[No Abstract] [Full Text] [Related]
2. Advances in the treatment of multiple myeloma: a nursing perspective.
Barrick M
ONS News; 2006; 21(8 Suppl):15-6. PubMed ID: 16925133
[No Abstract] [Full Text] [Related]
3. Myeloma: making sense of a complex blood cancer.
Kelly MB; Meenaghan T; Dowling M
Br J Nurs; 2010 Dec 9-2011 Jan 13; 19(22):1415-21. PubMed ID: 21139523
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma.
Kyle RA; Rajkumar SV
N Engl J Med; 2004 Oct; 351(18):1860-73. PubMed ID: 15509819
[No Abstract] [Full Text] [Related]
5. Multiple myeloma: the present and the future.
Joshua DE
Med J Aust; 2005 Oct; 183(7):344. PubMed ID: 16201949
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma.
Raab MS; Podar K; Breitkreutz I; Richardson PG; Anderson KC
Lancet; 2009 Jul; 374(9686):324-39. PubMed ID: 19541364
[TBL] [Abstract][Full Text] [Related]
7. Maintenance treatment in multiple myeloma.
Harousseau JL
Ann Oncol; 2008 Jun; 19 Suppl 4():iv54-5. PubMed ID: 18519405
[No Abstract] [Full Text] [Related]
8. Advances in the treatment of MDS, multiple myeloma, and CLL.
Snively A
ONS Connect; 2007; 22(8 Suppl):55-6. PubMed ID: 17824566
[No Abstract] [Full Text] [Related]
9. Frontline treatment of multiple myeloma.
Fonseca R
Hematology; 2012 Apr; 17 Suppl 1():S101-4. PubMed ID: 22507793
[TBL] [Abstract][Full Text] [Related]
10. [Molecular targeting therapy for multiple myeloma].
Takatoku M
Nihon Rinsho; 2007 Dec; 65(12):2345-50. PubMed ID: 18069281
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma patient care: treatment options and nursing considerations.
McGee L
ONS Connect; 2007; 22(8 Suppl):67-8. PubMed ID: 17824572
[No Abstract] [Full Text] [Related]
12. New treatments in multiple myeloma: beyond optimal treatment.
Harousseau JL
Ann Oncol; 2008 Jul; 19 Suppl 5():v68-70. PubMed ID: 18611904
[No Abstract] [Full Text] [Related]
13. Proteasome inhibition in cancer therapy.
Smith GG
J Infus Nurs; 2005; 28(4):258-64. PubMed ID: 16106209
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma: treatment evolution.
San Miguel JF; Mateos MV; Ocio E; Garcia-Sanz R
Hematology; 2012 Apr; 17 Suppl 1():S3-6. PubMed ID: 22507766
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition therapy: assessing the clinical implications in hematologic diseases.
ONS News; 2004; 19(9 Suppl):71-2. PubMed ID: 15478596
[TBL] [Abstract][Full Text] [Related]
16. Managing patients with multiple myeloma and mantle cell lymphoma: where are we now?
Amen K
ONS Connect; 2007; 22(8 Suppl):63-4. PubMed ID: 17824570
[No Abstract] [Full Text] [Related]
17. [Treatment of myeloma when high dose therapy is not possible. New drugs--alternatives for elderly patients].
Mellstedt H; Gimsing P; Waage A
Lakartidningen; 2011 Oct 19-25; 108(42):2090-4. PubMed ID: 22165535
[No Abstract] [Full Text] [Related]
18. Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications.
Colson K; Doss DS; Swift R; Tariman J; Thomas TE
Clin J Oncol Nurs; 2004 Oct; 8(5):473-80. PubMed ID: 15515281
[TBL] [Abstract][Full Text] [Related]
19. Clinical updates and nursing considerations for patients with multiple myeloma.
Faiman B
Clin J Oncol Nurs; 2007 Dec; 11(6):831-40. PubMed ID: 18063542
[TBL] [Abstract][Full Text] [Related]
20. [New strategy for the treatment of multiple myeloma].
Murakami H
Rinsho Ketsueki; 2005 Dec; 46(12):1263-72. PubMed ID: 16447798
[No Abstract] [Full Text] [Related]
[Next] [New Search]